IL17A and autoimmune disease: ILC3s have been associated with several autoimmune diseases, including inflammatory bowel disease, multiple sclerosis, psoriatic arthritis, and ankylosing spondylitis, either by direct evidence or by involvement of the IL17/IL22 axis (67–70).